Table 2 Participant clinical characteristics
|  | Glaucoma (n = 18) | Retinitis Pigmentosa (n = 19) |
|---|---|---|
Visual acuity (better eye) | ||
 Median | 20/27.5 | 20/40 |
 Range | 20/20–20/150 | 20/20–20/800 |
Visual fielda | ||
 Median | −16.05 dB | 10° |
 Range | −31.42- -9.86 dB | 4–20º |
Pelli-Robson contrast sensitivity (log contrast sensitivity) | ||
 Median | 1.1 | 1.2 |
 Range | 0.5–1.5 | 0.00–1.7 |
Duration of disease (years) | ||
 Median | 10 | 26 |
 Range | 1–22 | 3–61 |
Other ocular comorbidity | ||
 Cataract | 89% | 58% |
 Usher Syndrome | 0% | 26% |
 Other | 6% | 11% |
Medical comorbidity | ||
 Yes | 94% | 53% |
 Depression or anxiety | 22% | 32% |
 Hypertension | 61% | 0% |
 Heart Disease | 22% | 0% |
 Stroke | 11% | 0% |
 Diabetes | 28% | 0% |
 Lung Disease | 22% | 0% |
 Arthritis | 39% | 0% |
 Other | 28% | 21% |
Low vision device use | ||
 Yes | 50% | 84% |
Low vision rehabilitation experience | ||
 Yes | 39% | 63% |